COX-2 Gene increases tongue cancer cell proliferation and invasion through VEGF-C pathway (Q39633227)

13 September 2017

title

COX-2 Gene increases tongue cancer cell proliferation and invasion through VEGF-C pathway (English)

1 reference

13 September 2017

1 reference

Yan-Hong Wang

1

1 reference

13 September 2017

Ming-Wei Wu

2

1 reference

13 September 2017

An-Kui Yang

3

1 reference

13 September 2017

Wei-Dong Zhang

4

1 reference

13 September 2017

Jian Sun

5

1 reference

13 September 2017

Tian-Run Liu

6

1 reference

13 September 2017

Yan-Feng Chen

7

1 reference

13 September 2017

publication date

11 November 2010

1 reference

13 September 2017

1 reference

13 September 2017

volume

28 Suppl 1

1 reference

13 September 2017

page(s)

S360-6

1 reference

Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9737-3

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9737-3

shRNA-targeted cyclooxygenase (COX)-2 inhibits proliferation, reduces invasion and enhances chemosensitivity in laryngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9737-3

Cyclooxygenase-2 expression during immortalization and breast cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9737-3

Expression of COX-2 in stomach carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9737-3

Cox-2 expression in ovarian malignancies: a review of the clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9737-3

Many actions of cyclooxygenase-2 in cellular dynamics and in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9737-3

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9737-3

Cancer and cyclooxygenase-2 (COX-2) inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9737-3

Is cyclooxygenase-2 the alpha and the omega in cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9737-3

The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9737-3

Side effects of conventional nonsteroidal anti-inflammatory drugs and celecoxib: more similarities than differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9737-3

Increased risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9737-3

Che-1 promotes tumor cell survival by sustaining mutant p53 transcription and inhibiting DNA damage response activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9737-3

Lymphangiogenesis in development and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9737-3

Tumor lymphangiogenesis and metastatic spread-new players begin to emerge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9737-3

Lymphangiogenesis and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9737-3

Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9737-3

[Reasons for recurrence and prognostic analysis of early stage squamous cell carcinoma of the oral tongue]

21 January 2018

1 reference

12 December 2020

Survival time and prognostic factors of oral cancer in Ubon Ratchathani Cancer Center.

1 reference

12 December 2020

[Treatment and prognostic analysis of 92 cases with advanced mobile tongue squamous cell carcinoma]

1 reference

12 December 2020

Role of cyclooxygenase-2 in tumor progression and immune regulation in lung cancer.

1 reference

12 December 2020

Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer

1 reference

12 December 2020

Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer

1 reference

12 December 2020

Cationic polymer-mediated small interfering RNA delivery for P-glycoprotein down-regulation in tumor cells.

1 reference

12 December 2020

Cyclo-oxygenase-2 over-expression is associated with human esophageal squamous cell carcinoma

1 reference

12 December 2020

Significance of cyclooxygenase-2 as a chemotherapeutic target in hepatocellular carcinoma

1 reference

12 December 2020

Inhibitive effect of celecoxib on the adhesion and invasion of human tongue squamous carcinoma cells to extracellular matrix via down regulation of MMP-2 expression

1 reference

12 December 2020

Prognostic importance of COX-2 expression in patients with colorectal cancer

1 reference

12 December 2020

Relationship between cyclooxygenase-2 and human epidermal growth factor receptor 2 in vascular endothelial growth factor C up-regulation and lymphangiogenesis in human breast cancer.

1 reference

12 December 2020

10.1007/S12032-010-9737-3

Identifiers

DOI

1 reference

release_pk6c323ul5g53ceve5hdoekbia

13 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pk6c323ul5g53ceve5hdoekbia

24 November 2022

mapped directly with Wikidata item

1 reference